Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · JUPITER NEUROSCIENCES, INC. (JUNS)

Jupiter Neurosciences executives forgive $875,315 in accrued pay owed by the company

Neutral Impact 3 of 5 financing Written later

On August 26, 2026, Jupiter Neurosciences' chairman and CEO, president and COO, chief scientific officer, and chief administrative officer irrevocably forgave $875,315 of accrued, unpaid compensation owed to them by the company. The filing says the forgiveness was gratuitous, with no equity issued and no cash or other consideration paid, so the change removes liabilities from the balance sheet without a cash outlay.

Key points

  • Total forgiven: $875,315 of accrued salaries reflected as liabilities on the balance sheet
  • Christer Rosén (Chairman and CEO and Director) forgave $356,024; Marshall Hayward, Ph.D. (Chief Scientific Officer and Director) forgave $287,075
  • Alison Silva (President, COO and Director) forgave $81,431; Alexander Rosén (Chief Administrative Officer) forgave $150,785
  • Effective August 26, 2026; the company issued no equity or cash in exchange, and each agreement includes a general release of related claims

The filing

CompanyJUPITER NEUROSCIENCES, INC. (JUNS)
Form8-K, current report
Filed with the SECAug 27, 2026, 6:30 AM ET
Accession number0001493152-26-040308

Items reported: 1.01 Material Definitive Agreement5.02 Director / Officer Change8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 27, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.